L20- Drugs Used in Disorders of Coagulation Flashcards
list the 3 steps hemostasis
1) primary hemostasis- platelet aggregation
2) secondary hemostasis- coagulation
3) fibrinolysis: via plasmin
plasmin breaks down….
- fibrinogen
- fibrin
=> degradation products
what are the types / functions of drugs used in disorders of coagulation
1) drugs used to reduce clotting
2) drugs used to reduce bleeding
what are the types of drugs used to reduce clotting
- platelet aggregation inhibitors
- anticoagulants
- thrombolytics
platelet aggregation inhibitors act on…..
- dec platelet synthesis
- inhibit actions of chemical signals
what are the 4 platelet aggregation inhibitors
- cyclooxygenase inhibitors
- ADP receptor blockers
- phosphodiesterase inhibitors
- blocker of platelet GP IIb/IIIa receptors
ASA functions as a (1) inhibitor via (2) interaction. The end goal and result is to decrease (3) levels which are responsible for (4).
1- COX (1 and 2)
2- irreversible acetylation
3- TX-A2
4- platelet degranulation and aggregation // vasoconstriction
describe the platelet aggregation interaction
1 fibrinogen binding to 2 GP IIb/IIIa on 2 different platelets
note- this reaction / interaction occurs as a result of Ca influx
ASA is used for…..
- prophylactic Tx of TIA/CVA (transient cerebral ischemia)
- reduce incidence of recurrent MI / dec mortality in post-MI patients
(1) and (2) are the ADP receptor blockers that work via a (3) interaction with (4).
- indicate whether (1)/(2) is preferred and why
1- clopidogrel (preferred b/c fewer adverse effects)
2- ticlopidine
3- irreversible
4- P2Y12 (one of two ADP receptors)
Clopidogrel is a prodrug that is converted to active metabolite via (1). List the contraindications for using clopidogrel, (2).
1- CYP2C19
2: (do not use….)
- in poor CYP2C19 metabolizers
- with Omeprazole, a CYP2C19 inhibitor
clopidogrel is used for….
reduce rate of stroke, MI, death in patients with recent MI, stroke OR with acute coronary syndrome
list the 2 phosphodiesterase inhibitors and their associated uses
- Dipyridamole: stroke prevention
- Cilostazol: intermittent claudication
list the blockers of platelet GP IIb/IIIa receptors (indicate preferred drug) and what they treat
Abciximab, Eptifibatide, Tirofiban** (preferred)
-adjuncts in PCI (stent/angioplasty) for prevention of cardiac ischemic complications
list anticoagulants
- indirect thrombin (IIa) and factor Xa inhibitors
- vitamin K antagonist
- direct thrombin (IIa) inhibitors
- direct factor Xa inhibitors
list the indirect thrombin (IIa) and factor Xa inhibitors
- unfractionated heparin (UFH)
- low molecular weight heparins (LMWH)
- fondaparinux
UFH and LMWH are administered via (1), it has a (fast/slow) action and used for (3)
1- injectable
2- rapid
3- interfere with formation of thrombi
UFH and LMWH:
1) describe structure (+ weight
(2) explain source
1- mixture of straight-chain sulfated mucopolysaccharides (highly sulfonated => very negative)
-UFH: 5000-30000 MW
-LMWH (enoxaparin): 1000-5000 MW
2- isolated from bovine lung or porcine intestinal mucosa